|
TWISTNB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
8.59130000030461E-07 |
| Normal-vs-Stage3 |
9.91873250200115E-13 |
| Normal-vs-Stage4 |
9.88098491916389E-15 |
| Stage1-vs-Stage2 |
2.199600E-01 |
| Stage1-vs-Stage3 |
4.737400E-01 |
| Stage1-vs-Stage4 |
1.242170E-02 |
| Stage2-vs-Stage3 |
1.477390E-01 |
| Stage2-vs-Stage4 |
1.035740E-02 |
| Stage3-vs-Stage4 |
1.277390E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.63165000000021E-05 |
| Normal-vs-Asian |
6.32000007882993E-10 |
| Caucasian-vs-AfricanAmerican |
5.093400E-01 |
| Caucasian-vs-Asian |
7.186200E-01 |
| AfricanAmerican-vs-Asian |
7.175600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22044604925031E-16 |
| Normal-vs-Female |
1.6251444634463E-12 |
| Male-vs-Female |
1.350420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.67366120962242E-12 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
2.60590438116992E-11 |
| Normal-vs-Age(81-100Yrs) |
1.183990E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.219200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.593600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.968400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.074600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.494800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.509000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.402420E-01 |
| Classical-VS-Follicular |
6.387000E-01 |
| Classical-VS-Other |
3.405900E-02 |
| Classical-VS-Normal |
1.62947433324234E-12 |
| Tall-VS-Follicular |
3.183600E-01 |
| Tall-VS-Other |
1.735180E-01 |
| Tall-VS-Normal |
5.73909997303446E-09 |
| Follicular-VS-Other |
7.936300E-02 |
| Follicular-VS-Normal |
2.50889975461632E-10 |
| Other-VS-Normal |
1.87584999999935E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4210854715202E-14 |
| Normal-vs-N1 |
3.13971071363994E-13 |
| N0-vs-N1 |
1.414010E-01 |
|
|
